WILLIAM FULLER: Open Payments
NPI 1518939024 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 25 payments from 12 companies in 2025. Trend: 2023 $217 · 2024 $552 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $166 |
| Janssen Scientific Affairs, LLC | 1 | $129 |
| ACADIA Pharmaceuticals Inc | 3 | $90 |
| Teva Pharmaceuticals USA, Inc. | 4 | $68 |
| Corium, LLC | 4 | $51 |
| Axsome Therapeutics, Inc. | 3 | $47 |
| Alkermes, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: COBENFY, INVEGA SUSTENNA, NUPLAZID, Azstarys, Auvelity, UZEDY, ARISTADA, AUSTEDO XR.
Industry payments across SD — which companies pay providers there.
